FourKites Bolsters its Management Team with Supply Chain Industry Veterans
19.1.2023 11:00:00 EET | Business Wire | Press release
Leading supply chain visibility company FourKites today announces it has strengthened its executive team with the appointment of a Chief Strategy Officer and a Vice President of Global Customer Success. FourKites’ leadership position, rapid growth and momentum in the supply chain visibility market continue to make it a destination for top talent in the industry.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230119005040/en/
FourKites Bolsters its Management Team with Supply Chain Industry Veterans (Photo: Business Wire)
Fabrizio (Fab) Brasca has been promoted to FourKites Chief Strategy Officer. Brasca joined FourKites last year as EVP, Industry and Market Strategy. As Chief Strategy Officer, he will continue to lead the company’s Industry teams and take on expanded responsibilities including the strategy for FourKites’ Global Alliances division and leadership of the customer value engineering and pre-sales functions.
Additionally, Rebecca Nerad joined FourKites as Vice President of Global Customer Success. Nerad has over 20 years of experience in the supply chain industry, holding customer success roles for companies such as i2 Technologies, JDA Software and Bristlecone. Most recently, she served as Vice President of Customer Success at e2open, maximising solution adoption, expansion and retention. Nerad and her team will remain focused on building strong relationships and driving value with customers as FourKites expands.
“Fab has played a pivotal role in establishing FourKites’ industry team and building a vertical go-to-market strategy. His industry knowledge and partnership with customers will serve him well as he helps FourKites develop and execute its strategy more broadly,” says FourKites founder and CEO Mathew Elenjickal. “And Rebecca is a remarkable talent and a great fit for our culture, where we pride ourselves on true partnership with our customers. I look forward to working with both of them, as we continue toward our goal of helping customers achieve 100% visibility everywhere.”
FourKites continues to attract top-level talent from the industry as it gains recognition as a great place to work and a pioneering innovator in the real-time visibility market. This month, FourKites was named to Built In’s list of Best Places to Work in Chicago for the third consecutive year, and it has been named a Great Place to Work in India by the Great Places Institute for five consecutive years. The company has been recognised for its ability to solve the complex pain points of enterprise customers, having been named a Leader in Gartner’s Magic Quadrant for Real-time Transportation Visibility Platforms for its ability to execute, and with the highest completeness of vision. FourKites also scored the highest for Fortune 500 businesses with complex needs, according to Gartner’s Critical Capabilities for Real-Time Transportation Visibility Platforms report. Other accolades include Inc. Magazine’s Best in Business list in the Logistics & Transportation category, AI Trailblazer by Everest Group, the 2022 Top Food Chain Technology providers, Top Green Provider, and BlueYonder's GTM Partner of the Year in 2022.
About FourKites
Leading supply chain visibility platform FourKites® extends visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 3 million shipments daily across road, rail, ocean, air, parcel and last mile, and reaching over 200 countries and territories, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,200 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230119005040/en/
Contact information
Scott Johnston
European PR Director, FourKites
+31 62 147 8442
scott.johnston@fourkites.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
European Commission Approves DAYBU ® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union24.8.2026 10:01:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the European Commission (EC) has granted marketing authorization for DAYBU (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older, making it the first and only treatment approved for Rett syndrome in the European Union (EU). “The approval of DAYBU marks a significant milestone for the Rett syndrome community in the EU and advances our mission to bring this innovative treatment to patients and families who have long faced a profound unmet medical need,” said Catherine Owen Adams, Acadia’s Chief Executive Officer. “For people living with Rett syndrome, a devastating rare neurodevelopmental disorder, there have been no approved treatment options in the EU. We are proud to make DAYBU available and look forward to supporting patients, caregivers, and healthcare providers gain access to treatment." The DAYBU marketing authorization in the EU is prim
ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 124.8.2026 09:36:00 EEST | Press release
Takeda (TOKYO:4502/NYSE:TAK) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults. ORZEYFUL is a first-in-class oral orexin receptor 2 (OX2R) agonist and the only medicine indicated in Japan to treat the disease holistically rather than individual symptoms. The discovery of this new class of medicine originated in Takeda's laboratories in Japan. Takeda is proceeding with launch preparations and expects to make ORZEYFUL available as quickly as possible. “Our discovery of the first orexin agonist is a successful representation of Japan-originated science that will directly impact people around the world living with narcolepsy type 1,” said Julie Kim, president and chief executive officer of Takeda. “With the potential to redefine narcolepsy type 1 care, ORZEYFUL is the first validation of our broader orexin strategy, demonstrating how scientifi
Fasset Hits $1B Valuation as SBI Group Leads $68M Series C to Scale AI-Powered Stablecoin Neobanking24.8.2026 09:03:00 EEST | Press release
Fasset, the AI-powered stablecoin neobanking platform, today announced it has raised $68 million in Series C funding at a $1 billion valuation. The financing was led by SBI Group and follows Fasset’s $51 million Series B earlier this year, which brought Speedinvest onto the cap table alongside a group of strategic investors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260823503947/en/ Mohammad Raafi Hossain, Co-Founder and CEO, Fasset The new capital will support the expansion of Own Network, Fasset’s regulated financial network that connects banks, telcos, payment and liquidity providers to enable settlement across international markets. Fasset will also increase investment in agentic AI-enabled systems supporting corridor banking, stablecoin settlement and tokenized asset infrastructure. After raising Series B in May, Fasset has now raised a total of $119 million in 2026. The financing marks Fasset’s entry into the glob
Zanders Expands DACH Region with New Office in Vienna, Austria24.8.2026 08:11:00 EEST | Press release
Zanders, the global treasury, risk, and technology consultancy, today announced a significant expansion of its DACH region with the opening of a new office in Vienna. The move builds on Zanders' continued growth across Germany, Austria, and Switzerland, and marks another step in the firm's strategy of deepening its presence in the markets where client demand for specialized treasury, risk, and corporate finance advisory is growing fastest. DACH has been one of Zanders' priority regions for several years, with the firm steadily expanding its team and client base across Germany and Switzerland. Austria represents a natural next step in that growth: in conversations with clients in the market, Zanders has seen growing interest in treasury transformation and financing support, as companies work through interest rate volatility, refinancing needs, and a broader shift toward more digitized, centralized treasury operations. The new Vienna office allows Zanders to be closer to clients' operati
Novotech Strengthens Presence in Japan with Opening of Tokyo Office24.8.2026 02:01:00 EEST | Press release
Novotech, a leading global biotech CRO and full-service clinical research organization, has strengthened its established presence in Japan with the opening of a new office in Tokyo. The investment builds on Novotech’s existing operations and clinical trial activity in Japan and further enhances its ability to support Japanese biopharma companies as they advance programs regionally and across key international markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260823592174/en/ Takeshi Mori, Novotech Country Head, Japan The Tokyo office will serve as a strategic hub for Novotech’s growing operations in Japan, providing enhanced local expertise and strengthening collaboration with clients, partners, research institutions, and innovation ecosystems across the region. Novotech is currently supporting ongoing studies in Japan and provides sponsors with integrated support across early-phase clinical development in Australia, F
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom